Autoplaque vs uMI Panvivo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)
VS
by United Imaging Healthcare

AI Verdict

These tools are adjacent rather than direct competitors, as Autoplaque is specialized AI-powered software for quantitative analysis of coronary plaques from CT angiography images. In contrast, uMI Panvivo is an AI-powered PET/CT imaging system designed for broad diagnostic precision across oncology, cardiology, and neurology, focusing on image acquisition and workflow. While both leverage AI in cardiology and radiology, they serve distinct functions within the diagnostic process.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of pre-existing CT angiography images to precisely characterize coronary plaques and luminal stenoses. This tool is ideal for cardiologists and radiologists seeking to enhance heart attack risk prediction and guide treatment decisions through detailed, automated post-processing of CTA data.

View Autoplaque →

Choose uMI Panvivo if…

Choose uMI Panvivo if you require a comprehensive, state-of-the-art PET/CT imaging system for advanced diagnostic precision across oncology, cardiology, and neurology. This system is best suited for institutions looking to acquire high-resolution metabolic and anatomical images with intelligent AI-powered workflows, especially when considering a new installation or upgrade of their nuclear medicine or imaging department.

View uMI Panvivo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Autoplaque uMI Panvivo
Deployment Workstation-based post-processing application, runs on Windows or Mac OS. On-premise
FDA Status Cleared AI-estimated Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Autoplaque uMI Panvivo
Company Cedars-Sinai Medical Center: AIM Shanghai United Imaging Healthcare Co., Ltd.
Primary Purpose AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. AI-powered PET/CT system offering advanced diagnostic precision with high-resolution imaging and intelligent workflows for oncology, cardiology, and neurology.
Tagline AI-Powered Quantitative Analysis for Coronary Plaque and Stenosis Equal Healthcare for Allu2122
Primary Application Areas Cardiology AI, Radiology & Imaging AI (Specialties: Cardiology, Radiology) Cardiology AI, Oncology AI, Radiology & Imaging AI (Specialties: Nuclear Medicine, Oncology, Radiology)
Key Differentiating Feature AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses. High NEMA spatial resolution (2.9mm), exceptional TOF timing resolution (219 ps), air-cooled compact design.

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and uMI Panvivo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Autoplaque is an AI-powered software designed for the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. uMI Panvivo is an AI-powered PET/CT system that offers advanced diagnostic precision with high-resolution imaging and intelligent workflows across multiple specialties.
Autoplaque is primarily for Cardiology and Radiology, focusing on the analysis of coronary anatomy and pathology from CT Angiographic images. uMI Panvivo supports Nuclear Medicine, Oncology, and Radiology, providing advanced diagnostic capabilities for oncology, cardiology, and neurology.
Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, and automated vessel, plaque, and lumen segmentation that is reviewable and editable by clinicians. uMI Panvivo features an AI-powered workflow that includes uVision, EasyRange, OncoFocus, NeuroFocus, and uExcel DPR.
AI Tool Finder
AI-powered search. Results may not be comprehensive.